SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tonyt who wrote (550)8/20/1997 4:15:00 PM
From: Henry Niman   of 2173
 
Tony, You don't have to worry about LGND. I just talked to IR. All major announcements are "on track" including diabetes deal slated to be announced end of 3Q beginning 4Q. LGND is presenting at 6 major investment conferences (BioCentury, Bear Stearns, UBS, Oppenheimer, Robertson Stephens, Hambrecht & Quist) between now and beginning of Jan and I expect the news to come out hot and heavy (including European Diabetes data, mega-diabetes deal, launch of US diabetes clinical trials - Phase II/III, and pivotol Phase III data on Targretin and Panretin).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News